Published date: 7 January 2022
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Location of contract
Any region
Value of contract
£3,500,000,000
Procurement reference
tender_294050/1022419
Published date
7 January 2022
Closing date
14 February 2022
Closing time
12pm
Contract start date
1 April 2022
Contract end date
31 March 2024
Contract type
Supply contract
Procedure type
Open procedure (below threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The Tender is to establish a framework agreement for the supply of a range of aseptically prepared, batch manufactured anti-cancer chemotherapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific chemotherapy. All chemotherapy doses will be based on the National Dose Banded Chemotherapy Standardised Product Specifications and National Dose Banding Tables, where a specification exists.
The duration of the framework agreement will be two (2) years initial period with the option of extending for up to twenty four (24) months, at HealthTrust Europe's discretion.
About the buyer
Contact name
HealthTrust Europe
Address
19 George Road
Birmingham
B15 1NU
England
Share this notice
Closing: 14 February 2022, 12pm
All content is available under the
